JC

Jason M. Cox

Merck: 24 patents #368 of 9,382Top 4%
KB Kinnate Biopharma: 8 patents #3 of 15Top 20%
Overall (All Time): #104,401 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 25 most recent of 33 patents

Patent #TitleCo-InventorsDate
12331039 Inhibitors of fibroblast growth factor receptor kinases Stephen W. Kaldor, John Tyhonas, Eric A. Murphy, Toufike Kanouni, Lee D. Arnold +1 more 2025-06-17
12247031 Cyclobutyl pyrazolopyrimidine PDE9 inhibitors Ashok Arasappan, John S. Debenham, Zhuyan Guo, Zhong Lai, Dongfang Meng 2025-03-11
12246008 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels Christopher James Bungard, Helen Chen, Liangqin Guo, Michael J. Kelly, III, Ronald Kim +9 more 2025-03-11
12195445 2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors Ashok Arasappan, Ian M. Bell, Michael J. Breslin, Christopher James Bungard, Christopher S. Burgey +11 more 2025-01-14
12122800 Inhibitors of MEK kinase Toufike Kanouni, Robert S. KANIA 2024-10-22
11814384 Inhibtors of Raf kinases Toufike Kanouni, John Tyhonas, Robert S. KANIA, Subhas J. Chakravorty, Young K. Chen 2023-11-14
11802122 2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors Ashok Arasappan, Ian M. Bell, Christopher James Bungard, Christopher S. Burgey, Michael J. Kelly, III +7 more 2023-10-31
11780862 Inhibitors of MEK kinase Toufike Kanouni, Robert S. KANIA 2023-10-10
11753395 Inhibitors of MET kinase Xiaohu Ouyang, Toufike Kanouni, John Tyhonas, Robert S. KANIA 2023-09-12
11746095 Inhibtors of RAF kinases Stephen W. Kaldor, Toufike Kanouni, Eric A. Murphy, Robert S. KANIA 2023-09-05
11407737 Inhibitors of RAF kinases Stephen W. Kaldor, Toufike Kanouni, John Tyhonas, Eric A. Murphy, Robert S. KANIA 2022-08-09
11377438 2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors Ashok Arasappan, Ian M. Bell, Michael J. Breslin, Christopher James Bungard, Christopher S. Burgey +11 more 2022-07-05
11377431 Inhibitors of RAF kinases Stephen W. Kaldor, Toufike Kanouni, Eric A. Murphy, Robert S. KANIA 2022-07-05
11345681 Inhibitors of fibroblast growth factor receptor kinases Stephen W. Kaldor, John Tyhonas, Eric A. Murphy, Toufike Kanouni, Lee D. Arnold +1 more 2022-05-31
11161819 Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists Gregory L. Adams, John S. Debenham, Scott D. Edmondson, Eric J. Gilbert, Yan Guo +15 more 2021-11-02
11028092 Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors Ashok Arasappan, John S. Debenham, Zahid Hussain, Derun Li, Dongfang Meng +1 more 2021-06-08
10934294 Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors Ashok Arasappan, John S. Debenham, Zhuyan Guo, Jiafang He, Zahid Hussain +5 more 2021-03-02
10864211 Hydroxy isoxazole compounds useful as GPR120 agonists John S. Debenham, Ping Lan, Zhongxiang Sun, Zhe Feng, Chunrui Sun +9 more 2020-12-15
9708270 Substituted spiropiperidinyl compounds useful as GPR120 agonists Mariappan V. Chelliah, Hong Dong Chu, John S. Debenham, Keith Eagen, Ping Lan +7 more 2017-07-18
9505730 Mineralocorticoid receptor antagonists Hong Shen, Christine Yang, Zhicai Wu 2016-11-29
9193717 Mineralocorticoid receptor antagonists Hong Shen, Christine Yang, Kun Liu 2015-11-24
9085568 Mineralocorticoid receptor antagonists Hong Shen, Hong Dong Chu 2015-07-21
8716482 Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Tesfaye Biftu, Hong Dong Chu, Danqing Feng, Ann E. Weber 2014-05-06
8653059 Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Tesfaye Biftu, Danqing Feng, Ann E. Weber, Xiaoxia Qian, Jinyou Xu 2014-02-18
8143289 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Tesfaye Biftu, Ping Chen, Ann E. Weber 2012-03-27